The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Hosted on MSN
FDA approves J&J’s TECNIS PureSee intraocular lens
Johnson & Johnson (J&J) has received approval from the US Food and Drug Administration (FDA) for its TECNIS PureSee extended depth of focus (EDOF) intraocular lens (IOL), designed for use in cataract ...
Johnson & Johnson (NYSE: JNJ) announced U.S. Food and Drug Administration (FDA) approval of TECNIS PureSee IOL, an extended depth of focus (EDOF) intraocular lens (IOL) intended for use in cataract ...
Johnson & Johnson (NYSE: JNJ) will present data from two major studies supporting the performance of its recently FDA-approved TECNIS PureSee intraocular lens (IOL) at the 2026 American Society of ...
AUSTIN, TX, UNITED STATES, April 2, 2026 /EINPresswire.com/ — Dell Laser Consultants is proud to be among the first practices in the United States to offer the ...
Johnson & Johnson presented multi-region clinical results at ASCRS 2026 showing its FDA-approved TECNIS PureSee intraocular lens delivers exceptional distance and intermediate vision, high contrast ...
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Johnson & Johnson (NYSE:JNJ) received FDA approval for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results